EYE 2.56% 19.0¢ nova eye medical limited

Ann: EYE February sales update, page-39

  1. 16,296 Posts.
    lightbulb Created with Sketch. 4349
    The continuously increasing growth rate (ignoring the two months during the LCD period) is definitely very exciting. That trend should continue as they expand the sales team and we could potentially be looking at triple digit growth in the very near future. If that does happen sales will really explode, and will easily offset the currently low growth being generated outside of the US

    Even during the two LCD months it's quite impressive to still see how much sales continued to grow. The growth rate was down slightly but it was still vastly outperforming competitors, proving doctors do indeed see this new device as the best in class canaloplasty option. Not surprised, it's the only device that naturally and fully restores outflow rather than leaving a stent or tearing
 
watchlist Created with Sketch. Add EYE (ASX) to my watchlist
(20min delay)
Last
19.0¢
Change
-0.005(2.56%)
Mkt cap ! $43.52M
Open High Low Value Volume
19.0¢ 19.0¢ 19.0¢ $21.85K 115.0K

Buyers (Bids)

No. Vol. Price($)
3 74720 18.5¢
 

Sellers (Offers)

Price($) Vol. No.
19.0¢ 65402 4
View Market Depth
Last trade - 11.21am 18/09/2024 (20 minute delay) ?
EYE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.